Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
VELO Holds $0.0084 as Price Consolidates Above Fib 0.236, Mirroring 1,500% Historical Rally Setups

VELO Holds $0.0084 as Price Consolidates Above Fib 0.236, Mirroring 1,500% Historical Rally Setups

CryptonewslandCryptonewsland2025/10/26 03:45
By:by Francis E
  • Despite a 14.8% weekly drop, VELO remains within its macro accumulation channel, indicating consolidation rather than structural weakness.
  • Price stability near the $0.007–$0.0069 Fib 0.236 zone mirrors historical accumulation points that preceded major rallies.
  • Previous channel retests have yielded 1,400%–1,625% gains, reinforcing optimism for a similar breakout after the current retest phase.

Velo (VELO) is still trading in its macro accumulation channel and the token is trading at $0.008408 which is a decrease of 14.8% per week . The recent move suggests the retesting of the breakout zone on March 1, 2024, and this could mean that the asset is moving towards stabilization after several months of consistent upward movement. This trend is observed prior to the other rallies and it underscores how VELO tends to be compacted and spread out again.

Price Action and Fibonacci Retest Zones

The price is still within a strategic support level of between $0.007 and $0.0069 that is quite close to the Fib 0.236 retracement area. This can be revisited back to this level as history has demonstrated that VELO has taken advantage of this kind of dips to gain momentum. Despite the short-term decline, the structure still reflects accumulation behavior rather than weakness.

#VELO – MACRO ACCUMULATION PHASE ⚡️:

⚪️ #VELO Retest:
▫️ #VELO is simply retesting the breakout zone from March 1st, 2024 , a classic move before the next leg up.

▫️A dip toward the Fib 0.236 zone ($0.007–$0.0069) is still on the table, and if it happens… I’m diving in… pic.twitter.com/1QOg1xSWaC

— EGRAG CRYPTO (@egragcrypto) October 23, 2025

The Fib 0.5 level, near the midpoint of the retracement, represents what analysts often refer to as the “decision zone.” Although not a true Fibonacci ratio, it marks a key psychological battleground for traders. This level was tested in January 2025, rejected by VELO, and the company has been in the process of consolidating ever since. An obvious separation and re-test over Fib 0.5 might be an indication of an upward movement to an increase in the Fibonacci levels of $0.618, $0.702, and $0.786.

Channel Performance and Historical Context

Historically, VELO has shown notable performance each time it reached the lower boundary of its macro price channel. The first rebound produced a 1,400% increase, while the second delivered approximately 1,625%, averaging around 1,525% per cycle. These precedent rebounds were similar to retests of lower Fibonacci with a repeating technical pattern over time.

Support is currently close to $0.008102, whereas resistance is currently at 0.008684, indicating a small trading range. The setup suggests ongoing accumulation within a controlled structure. Notably, the overall pattern maintains alignment with long-term channel dynamics, implying potential for sustained movement once the retest phase concludes.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market